What does Aatmaj Health do?

Aatmaj Healthcare Ltd is a micro-cap company in the hospital industry, reporting net sales of 9 Cr and a net profit of 2 Cr for September 2023. It was incorporated in 2014 and became a public limited company in December 2022.

Overview:<BR>Aatmaj Healthcare Ltd operates in the hospital industry and is classified as a micro-cap company.<BR><BR>History:<BR>Aatmaj Healthcare Ltd was originally incorporated as Aatmaj Healthcare Private Limited in 2014. It transitioned to a public limited company and changed its name to Aatmaj Healthcare Limited on December 6, 2022. The most recent quarterly results reported net sales and net profit for September 2023.<BR><BR>Financial Snapshot:<BR>Net Sales: 9 Cr (Quarterly Results - Sep 2023) <BR>Net Profit: 2 Cr (Quarterly Results - Sep 2023) <BR>Market Cap: Rs 43 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 43.00 <BR>Industry P/E: 54 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.11 <BR>Return on Equity: 1.29% <BR>Price to Book: 0.86 <BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

When is the next results date for Aatmaj Health?

No Upcoming Board Meetings

Has Aatmaj Health declared dividend?

No Dividend History Available

Is Aatmaj Health overvalued or undervalued?

As of May 28, 2025, Aatmaj Health is overvalued with a PE ratio of 42.38 and low growth expectations, reflected in its poor financial metrics and significant underperformance compared to the Sensex.

As of 28 May 2025, Aatmaj Health has moved from a risky to a very expensive valuation grade. The company is currently overvalued, with a PE ratio of 42.38, an EV to EBITDA of 23.90, and a ROE of 1.29%. In comparison, peers such as Max Healthcare Institute Ltd. and Apollo Hospitals Enterprise Ltd. have significantly higher PE ratios of 100.29 and 69.03, respectively, indicating that Aatmaj Health's valuation is not justified by its earnings potential.<BR><BR>The company's financial metrics suggest a concerning outlook, particularly with a low ROCE of 1.43% and a PEG ratio of 0.00, which implies no growth expectations. Additionally, Aatmaj Health's stock has underperformed relative to the Sensex, showing a year-to-date decline of 19.87% compared to the Sensex's gain of 6.24%. This further reinforces the notion that the stock is overvalued in the current market environment.

What is the technical trend for Aatmaj Health?

As of May 5, 2025, Aatmaj Health's technical trend is mildly bearish, influenced by daily moving averages and monthly Bollinger Bands, despite some conflicting signals from weekly MACD and KST.

As of 5 May 2025, the technical trend for Aatmaj Health has changed from sideways to mildly bearish. The daily moving averages indicate a mildly bearish stance, while the weekly MACD and KST are mildly bullish, suggesting some conflicting signals. The Bollinger Bands show a bearish outlook on the monthly timeframe, and the OBV is mildly bearish on the weekly but mildly bullish on the monthly, indicating mixed momentum. Overall, the current technical stance is mildly bearish, driven primarily by the daily moving averages and the monthly Bollinger Bands.

Who are the peers of the Aatmaj Health?

Aatmaj Health's peers include Vaidya Sane, Lotus Eye Hospital, Sangani Hospital, Nidan Laboratories, Docmode Health, Shanmuga Hospital, KK Shah Hospital, Fortis Malar, Global Longlife, and Soni Medicare. Vaidya Sane shows strong management and growth, while Aatmaj Health has below-average growth and a 1-year return of -24.34%.

Peers: The peers of Aatmaj Health are Vaidya Sane, Lotus Eye Hospit, Sangani Hospital, Nidan Laborator., Docmode Health, Shanmuga Hos., KK Shah Hospital, Fortis Malar, Global Longlife, and Soni Medicare.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shanmuga Hos., while Average management risk is found at Lotus Eye Hospit and Docmode Health, and the rest have Below Average management risk. Good growth is noted at Vaidya Sane, while Below Average growth is seen at Lotus Eye Hospit, Sangani Hospital, Nidan Laborator., Docmode Health, Aatmaj Health, and the rest. Good capital structure is present at Vaidya Sane, Lotus Eye Hospit, Sangani Hospital, Aatmaj Health, and KK Shah Hospital, while Below Average capital structure is found at Nidan Laborator., Docmode Health, Fortis Malar, Global Longlife, Soni Medicare, and the rest.<BR><BR>Return Snapshot: Vaidya Sane has the highest 1-year return at 13.72%, while Nidan Laborator. has the lowest at -41.34%, with Aatmaj Health's 1-year return at -24.34% being significantly lower than Vaidya Sane's. Additionally, Nidan Laborator., Docmode Health, and Global Longlife have negative six-month returns.

Who are the top shareholders of the Aatmaj Health?

The top shareholder of Aatmaj Health is promoter Tushar Karshanbhai Suvagiya, holding 46.22%. Neomile Corporate Advisory Limited is the largest public shareholder at 4.62%, while individual investors collectively own 24.96% of the shares, with no mutual funds or foreign institutional investors involved.

The top shareholders of Aatmaj Health include Tushar Karshanbhai Suvagiya, who is the promoter with the highest holding at 46.22%. Following him, the highest public shareholder is Neomile Corporate Advisory Limited, which holds 4.62%. Additionally, individual investors collectively hold 24.96% of the company's shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

How big is Aatmaj Health?

As of 24th July, Aatmaj Healthcare Ltd has a market capitalization of 45.00 Cr, with recent net sales of 21.99 Cr and a net profit of 5.19 Cr. The balance sheet for March 2024 shows shareholder's funds of 49.48 Cr and total assets of 57.68 Cr.

As of 24th July, Aatmaj Healthcare Ltd has a market capitalization of 45.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest two quarters, Aatmaj Healthcare Ltd reported Net Sales of 21.99 Cr and a Net Profit of 5.19 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 49.48 Cr and Total Assets of 57.68 Cr.

How has been the historical performance of Aatmaj Health?

Aatmaj Health's historical performance has shown significant volatility, with net sales and operating profit peaking in March 2023 before declining sharply by March 2025, despite growth in total assets and liabilities. Profit after tax fell from 5.91 Cr in March 2023 to 0.64 Cr in March 2025, while cash flow from operating activities improved to 3.00 Cr in March 2025 after a negative cash flow in the previous year.

Answer:<BR>The historical performance of Aatmaj Health shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aatmaj Health's net sales peaked at 27.16 Cr in March 2023 but have since declined to 19.53 Cr in March 2025. The total operating income followed a similar trend, reaching 27.16 Cr in March 2023 before dropping to 19.53 Cr in March 2025. The company's total expenditure, excluding depreciation, increased from 11.97 Cr in March 2021 to 17.98 Cr in March 2025, reflecting rising operational costs. Operating profit (PBDIT) saw a high of 9.86 Cr in March 2023 but fell to 2.87 Cr by March 2025. Profit before tax also decreased from 8.27 Cr in March 2023 to 1.07 Cr in March 2025, leading to a profit after tax of 0.64 Cr in March 2025, down from 5.91 Cr in March 2023. The company's total assets grew from 9.33 Cr in March 2020 to 63.25 Cr in March 2025, while total liabilities increased from 9.33 Cr to 63.25 Cr in the same period. Cash flow from operating activities turned positive at 3.00 Cr in March 2025, contrasting with a negative cash flow of -8.00 Cr in March 2024. Overall, Aatmaj Health has experienced a volatile financial trajectory, with notable declines in profitability despite growth in total assets and liabilities.

Which are the latest news on Aatmaj Health?

Why is Aatmaj Health falling/rising?

As of 04-Dec, Aatmaj Healthcare Ltd's stock price is stagnant at 19.50, having declined 2.50% over the past week and 6.25% over the past month, with a year-to-date drop of 18.41%. The stock's poor performance and reduced investor participation contribute to its lack of upward momentum.

As of 04-Dec, Aatmaj Healthcare Ltd's stock price is currently at 19.50, showing no change from the previous day. The stock has experienced a decline of 2.50% over the past week and a significant drop of 6.25% over the past month. Year-to-date, the stock has fallen by 18.41%, while over the past year, it has decreased by 23.08%. In contrast, the benchmark Sensex has shown positive performance, increasing by 10.10% year-to-date and 6.40% over the past year.<BR><BR>Today's performance indicates that the stock is in line with its sector, but it is important to note that it is currently trading higher than its 200-day moving average, although it is below the 5-day, 20-day, 50-day, and 100-day moving averages. This suggests a mixed technical outlook. Additionally, there has been a notable decline in investor participation, with delivery volume on December 3rd falling by 50% compared to the 5-day average. This decrease in trading activity may contribute to the stock's lack of upward momentum.<BR><BR>Overall, the combination of poor recent performance relative to both historical benchmarks and the decline in investor participation likely explains why Aatmaj Healthcare Ltd's stock price is not rising and remains stagnant at 19.50.